Drawing for Serial No. 79330040

USPTO serial 79330040

Serial No. 79330040

Reviewed by CopyMark Law Group

Reg. 6988075Status 700Registered
Filing date
Status date
Registration date
Feb 28, 2023
Examiner
STRUCK, ROBERT J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79330040?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jacqueline Zion

Jacqueline Zion Pearl Cohen Zedek Latzer Baratz LLP7 Times Square, 19th FlNew York, 10036CANADA

Goods and services

ClassDescriptionStatusFirst use
009Recorded computer software for aggregating and analyzing information relating to patient's conditions, patient's clinical data, patient's pharmacological data, patient's behavior and patient's hospitalization and emergency care events, for the purpose of providing pharmacological and clinical personal patient assessment, for optimizing healthcare providers' evaluation of health conditions and health risks with individual patients, for improving treatment decisions at the point of care, for optimizing allocation of healthcare resources, and for optimizing operational efficiency of healthcare providersACTIVE—
035Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare data for business purposes, namely information relating to patient's conditions, patient's clinical data, patient's pharmacological data, patient's behavior and patient's hospitalization and emergency care events, for business purposes, namely for optimizing healthcare providers' evaluation of health conditions and health risks with individual patients, for improving treatment decisions at the point of care, for optimizing allocation of healthcare resources, and for optimizing operational efficiency of healthcare providersACTIVE—
042Providing temporary use of non-downloadable cloud-based software for aggregating and analyzing information relating to patient's conditions, patient's clinical data, patient's pharmacological data, patient's behavior and patient's hospitalization and emergency care events, for the purpose of providing pharmacological and clinical personal patient assessment, for optimizing healthcare providers' evaluation of health conditions and health risks with individual patients, for improving treatment decisions at the point of care, for optimizing allocation of healthcare resources, and for optimizing operational efficiency of healthcare providers; software as a service (SAAS) services featuring software for aggregating and analyzing information relating to patient's conditions, patient's clinical data, patient's pharmacological data, patient's behavior and patient's hospitalization and emergency care events, for the purpose of providing pharmacological and clinical personal patient assessment, for optimizing healthcare providers' evaluation of health conditions and health risks with individual patients, for improving treatment decisions at the point of care, for optimizing allocation of healthcare resources, and for optimizing operational efficiency of healthcare providersACTIVE—
044Providing personalized healthcare and medical information in the nature of pharmacological and clinical personal patient assessment; consulting services in the field of healthcare, namely, analyzing information relating to patient's conditions, patient's clinical data, patient's pharmacological data, patient's behavior and patient's hospitalization and emergency care eventsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 26, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 2, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 1, 2023FIMPFINAL DISPOSITION PROCESSED—
May 28, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 28, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 28, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 13, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2022GPNXNOTIFICATION PROCESSED BY IB—
Nov 23, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 23, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 23, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 10, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 26, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 25, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 25, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 17, 2022RFNTREFUSAL PROCESSED BY IB—
Jul 22, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 22, 2022RFRRREFUSAL PROCESSED BY MPU—
Jun 28, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2022DOCKASSIGNED TO EXAMINER—
Jan 8, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 4, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 30, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance